Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27982407 | 0.98 | ALDH1A1 (0.54) | ALDH1A1CA2TDP1CYP3A4TSHR | |
| SCHEMBL17506679 | 0.90 | ALDH1A1 (0.48) | ALDH1A1CA2TDP1CYP3A4TSHR | |
| SCHEMBL14473790 | 0.85 | TSHR (0.45) | ALDH1A1CA2TDP1CYP3A4TSHR | |
| SCHEMBL524297 | 0.84 | ALDH1A1 (0.65) | ALDH1A1CA2TDP1CYP3A4TSHR | |
| SCHEMBL8209309 | 0.84 | ALDH1A1 (0.41) | ALDH1A1CA2TDP1CYP3A4TSHR | |
| SCHEMBL14125928 | 0.83 | ALDH1A1 (0.58) | ALDH1A1CA2TDP1CYP3A4TSHR | |
| SCHEMBL8371932 | 0.82 | TSHR (0.53) | ALDH1A1TDP1TSHR | |
| SCHEMBL8371931 | 0.82 | TSHR (0.53) | ALDH1A1TDP1TSHR | |
| SCHEMBL3884493 | 0.82 | ALDH1A1 (0.68) | ALDH1A1CA2TDP1CYP3A4TSHR | |
| SCHEMBL2989513 | 0.81 | ALDH1A1 (0.56) | ALDH1A1CA2TDP1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 494 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| US-RE50800-E1 | Pro-fragrance compounds | FIRMENICH SA (CH) | 2026-02-17 | — | — | US | claimed |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | GLYCOSCIENCE, S.L. (ES) | 2025-12-30 | — | — | US | claimed |
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | claimed |
| CN-119403908-A | Method for enhancing psychological performance and composition for use in the method | 弗门尼舍有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119281383-A | Mesoporous silica catalyst for catalyzing esterification reaction of tricarboxylic acid, and preparation method and application thereof | 中国科学院青岛生物能源与过程研究所 | 2025-01-10 | — | — | CN | claimed |
| CN-117683395-A | Preservation method of nano material, ink, preparation method of ink and electroluminescent device | 广东聚华印刷显示技术有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-117683394-A | Nanoparticle ink, preparation method thereof and electroluminescent device | 广东聚华印刷显示技术有限公司 | 2024-03-12 | — | — | CN | claimed |
| WO-2023247604-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| US-20230183284-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | GLYCOSCIENCE, S.L. (ES) | 2023-06-15 | — | — | US | claimed |
| WO-2001094442-A1 | ORGANOLEPTICALLY ACTIVE ALCOHOLS BONDED TO BIODEGRADABLE POLYESTER | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-13 | — | — | WO | claimed |
| WO-2001094438-A1 | URETHANE BASED ON ORGANOLEPTICALLY ACTIVE AROMATIC ALCOHOLS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-13 | — | — | WO | claimed |
| US-6262287-B1 | POLYSILOXANE OLIGOMERS | GIVAUDAN-ROURE (INTERNATIONAL) SA (CH) | 2001-07-17 | — | — | US | claimed |
| US-6133228-A | Slow release of fragrant compounds in perfumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or α-keto esters | FIRMENICH SA (CH) | 2000-10-17 | — | — | US | claimed |
| EP-0980863-A1 | Oxime carboxylic acid derivatives | Givaudan Roure (International) S.A. (CH) | 2000-02-23 | — | — | EP | claimed |
| EP-0953562-A1 | Beta, gamma-unsaturated delta-keto esters | Givaudan Roure (International) S.A. (CH) | 1999-11-03 | — | — | EP | claimed |
| US-5726345-A | Process for perfuming textiles | FIRMENICH S.A. (CH) | 1998-03-10 | — | — | US | claimed |
| US-5649979-A | LAUNDERING IN PRESENCE OF ESTER COMPOUND WHICH RELEASES FRAGRANT ALCOHOL, ALDEHYDE OR KETONE | FIRMENICH S.A. (CH) | 1997-07-22 | — | — | US | claimed |
| EP-0406415-B1 | METHOD OF PRODUCING AN ALKYLENE OXIDE ADDUCT | LION CORP (JP) | 1994-08-24 | — | — | EP | claimed |
| US-5086175-A | Reacting a diisocyanate with a monoalcohol; isocyanuration catalyst; coatings; adhesives; wear resistance; shelf-life | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-02-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183284-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | ADH1C, UGCG, ST6GAL1 | ALDH1A1 670/4885CA2 2840/4885TDP1 3355/4885 |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | EBP, MGAT1, MGAT3 | ALDH1A1 952/4885CA2 2724/4885TDP1 3585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.